Ascend Wellness Holdings (AAWH) Total Liabilities (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Total Liabilities came in at $947.9 million in Q1 2026, up 9.7% year-on-year from $864.0 million in Q1 2025, and down 0.7% quarter-over-quarter from $954.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Liabilities (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Liabilities history runs 7 years deep, the most recent figure standing at $947.9 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 9.7% year-over-year to $947.9 million in Q1 2026; TTM through Mar 2026 was $947.9 million, a 9.7% increase from a year earlier, with the FY2025 full-year figure at $954.5 million, up 15.2% from the prior year.
- Total Liabilities slipped to $947.9 million in Q1 2026 per AAWH's latest filing, from $954.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $954.5 million in Q4 2025 and bottomed at $556.2 million in Q1 2022.
- The 5-year median for Total Liabilities is $786.0 million (2024), against an average of $784.3 million.
- Across the five-year window, Total Liabilities soared 64.9% in 2022 and climbed 6.69% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $708.7 million in 2022, then grew by 9.58% to $776.7 million in 2023, then increased by 6.69% to $828.6 million in 2024, then grew by 15.2% to $954.5 million in 2025, then fell by 0.7% to $947.9 million in 2026.
- Per Business Quant, the three latest AAWH Total Liabilities figures stand at $947.9 million (Q1 2026), $954.5 million (Q4 2025), and $897.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 947.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 947.86 Mn |
| Dec 31, 2025 | 954.55 Mn |
| Sep 30, 2025 | 897.78 Mn |
| Jun 30, 2025 | 875.71 Mn |
| Mar 31, 2025 | 864.03 Mn |
| Dec 31, 2024 | 828.63 Mn |
| Sep 30, 2024 | 806.96 Mn |
| Jun 30, 2024 | 811.82 Mn |
| Mar 31, 2024 | 786.03 Mn |
| Dec 31, 2023 | 776.68 Mn |
| Sep 30, 2023 | 748.52 Mn |
| Jun 30, 2023 | 733.61 Mn |
| Mar 31, 2023 | 721.13 Mn |
| Dec 31, 2022 | 708.75 Mn |
| Sep 30, 2022 | 673.15 Mn |
| Jun 30, 2022 | 642.17 Mn |
| Mar 31, 2022 | 556.18 Mn |
| Dec 31, 2021 | 546.96 Mn |
| Sep 30, 2021 | 532.85 Mn |
| Jun 30, 2021 | 389.44 Mn |